SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - Euronext Milan - FR0000120578 - Common Stock - Currency: EUR
Taking everything into account, 1SAN scores 5 out of 10 in our fundamental rating. 1SAN was compared to 50 industry peers in the Pharmaceuticals industry. 1SAN has an excellent profitability rating, but there are some minor concerns on its financial health. 1SAN has a correct valuation and a medium growth rate. 1SAN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
1SAN had a positive operating cash flow in the past year.
Each year in the past 5 years 1SAN has been profitable.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.77%, 1SAN is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 13.83%, 1SAN is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
1SAN has a Return On Invested Capital of 13.31%. This is in the better half of the industry: 1SAN outperforms 74.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SAN is significantly below the industry average of 14.77%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.31%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROIC | 13.31% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN's Profit Margin of 14.84% is fine compared to the rest of the industry. 1SAN outperforms 72.00% of its industry peers.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
With a decent Operating Margin value of 23.19%, 1SAN is doing good in the industry, outperforming 64.00% of the companies in the same industry.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin (70.78%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1SAN is still creating some value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for 1SAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
2.2 Solvency
1SAN has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as 1SAN would need 2.72 years to pay back of all of its debts.
The Debt to FCF ratio of 1SAN (2.72) is better than 78.00% of its industry peers.
1SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1SAN (0.18) is better than 74.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Altman-Z | N/A |
ROIC/WACC1.78
WACC7.47%
2.3 Liquidity
1SAN has a Current Ratio of 1.37. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, 1SAN is in line with its industry, outperforming 52.00% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that 1SAN may have some problems paying its short term obligations.
1SAN has a worse Quick ratio (0.69) than 74.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -0.52% in the last year.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 5.52% in the past year.
1SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
3.2 Future
Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 7.73% on average per year.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.59% yearly.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.59%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1SAN is valuated reasonably with a Price/Earnings ratio of 10.82.
78.00% of the companies in the same industry are more expensive than 1SAN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1SAN to the average of the S&P500 Index (27.48), we can say 1SAN is valued rather cheaply.
The Price/Forward Earnings ratio is 9.12, which indicates a very decent valuation of 1SAN.
82.00% of the companies in the same industry are more expensive than 1SAN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 1SAN to the average of the S&P500 Index (36.52), we can say 1SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.82 | ||
| Fwd PE | 9.12 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1SAN.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.19 | ||
| EV/EBITDA | 11 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.29
PEG (5Y)2.12
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.66%, 1SAN is a good candidate for dividend investing.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.00. 1SAN pays more dividend than 86.00% of the companies in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.66% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
46.28% of the earnings are spent on dividend by 1SAN. This is a bit on the high side, but may be sustainable.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP46.28%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
BIT:1SAN (7/16/2025, 7:00:00 PM)
83.2
+0.45 (+0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap202.60B
Analysts79.33
Price Target115.93 (39.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.66% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP46.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.18%
Max EPS beat(2)6.02%
EPS beat(4)3
Avg EPS beat(4)5.51%
Min EPS beat(4)-2.18%
Max EPS beat(4)14.5%
EPS beat(8)5
Avg EPS beat(8)2.86%
EPS beat(12)8
Avg EPS beat(12)3.25%
EPS beat(16)12
Avg EPS beat(16)3.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.57%
Max Revenue beat(2)-1.3%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.47%
Revenue beat(12)6
Avg Revenue beat(12)19.07%
Revenue beat(16)10
Avg Revenue beat(16)28.26%
PT rev (1m)-4.42%
PT rev (3m)-1.56%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)-5.58%
EPS NY rev (1m)0%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-4.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.82 | ||
| Fwd PE | 9.12 | ||
| P/S | 2.93 | ||
| P/FCF | 26.19 | ||
| P/OCF | 18.53 | ||
| P/B | 2.74 | ||
| P/tB | 19.74 | ||
| EV/EBITDA | 11 |
EPS(TTM)7.69
EY9.24%
EPS(NY)9.13
Fwd EY10.97%
FCF(TTM)3.18
FCFY3.82%
OCF(TTM)4.49
OCFY5.4%
SpS28.36
BVpS30.42
TBVpS4.22
PEG (NY)1.29
PEG (5Y)2.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROCE | 16.06% | ||
| ROIC | 13.31% | ||
| ROICexc | 14.47% | ||
| ROICexgc | 47.61% | ||
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% | ||
| FCFM | 11.2% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 55.78% | ||
| Profit Quality | 75.5% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.47%
ROIC/WACC1.78
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.59%
EBIT growth 1Y7.75%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y10.46%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%